US Medicare Boosts Abiomed Heart Device Payment
CHICAGO (Reuters) – Abiomed Inc., developer of the first self-contained artificial heart, on Thursday said that the U.S. Medicare program boosted the […]
World's Largest Resource for Cardiovascular Perfusion
CHICAGO (Reuters) – Abiomed Inc., developer of the first self-contained artificial heart, on Thursday said that the U.S. Medicare program boosted the […]
This review provides a description of structure and mechanisms of action of thrombin both in physiological and pathological processes. Furthermore, it summarizes laboratory tests that measure in vivo or ex vivo thrombin generation, and presents knowledge on the value of these biomarkers in bleeding disorders, cardiopulmonary bypass surgery, and thromboembolic risk assessment in different patient populations. Finally, this review outlines further perspectives on using thrombin generation biomarkers for research purposes and in clinical practice.
To describe the variability and determinants of the effect of extracorporeal CO2 removal (ECCO2R) on tidal volume (Vt), driving pressure (ΔP), and mechanical power (PowerRS) and to determine whether highly responsive patients can be identified for the purpose of predictive enrichment in ECCO2R trial design.